CD8A and neoplasm: Accordingly, co-delivery of the protein antigen and α-GalCer to CD8+cDCs by nanoparticles coated with anti-CD205 antibodies elicited potent antitumor responses in a preventive scheme and delayed tumor growth in a therapeutic setting, suggesting that this strategy optimizes iNKT cell-mediated immune response (109).